<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05094232</url>
  </required_header>
  <id_info>
    <org_study_id>EHD20PI01</org_study_id>
    <nct_id>NCT05094232</nct_id>
  </id_info>
  <brief_title>Coeliac Disease in Spain: Determination of Disease Prevalence and Risk Factors</brief_title>
  <official_title>Epidemiologic Evolution of Coeliac Disease in Spain and Risk Factors Influencing Disease Prevalence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Mutua de Terrassa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Mutua de Terrassa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous studies have showed that Coeliac Disease (CD) prevalence is significantly higher in&#xD;
      children compared with adults. The largest epidemiologic study carried out in Spain to date&#xD;
      (n=4230) reported a higher CD prevalence in children (1:71) than in adults (1:357) during&#xD;
      2004-2007. To study whether this difference was due to environmental factors influencing&#xD;
      infancy or the development of gluten tolerance with age, a natural history study in pediatric&#xD;
      age was initiated in 2013. Unexpectedly, the prevalence in children of 1-2 years of age was&#xD;
      lower (1:135) than the previously reported in 2004-2007 for that age group (1:25). During&#xD;
      follow-up, 1/3 of the asymptomatic cases showed reversion of the intestinal lesion and/or&#xD;
      negativization of CD serological markers while continuing on a gluten-containing diet.&#xD;
      Therefore, the development of gluten tolerance seems to have a major effect in age-related&#xD;
      differences in CD prevalence. However, gluten tolerance phenomenon does not explain the&#xD;
      differences found between the 2013-2019 and the 2004-2007 cohorts, suggesting that&#xD;
      environmental factors may contribute as well. Apart from genetic factors, several&#xD;
      environmental factors are believed to influence disease appearance, such as the time that&#xD;
      gluten is introduced to the diet, viral infections, type of birth, antibiotic treatments,&#xD;
      etc. Therefore, development of tolerance and environmental factors seem to equally play an&#xD;
      important role in age-related differences in CD prevalence. However, more data is needed in&#xD;
      order to know how environmental factors influence disease prevalence in Spain. Also, the&#xD;
      previous studies carried in Spain were performed in specific geographical areas: Asturias,&#xD;
      Basque Country and Catalonia using slightly different methodology and focused on different&#xD;
      age groups, thus making results comparison and global extrapolation challenging.&#xD;
&#xD;
      In this study, the investigators aim to determine global CD prevalence in Spain during&#xD;
      2020-2021 and: 1) compare it with the results obtained in previous studies; and 2) identify&#xD;
      whether there are any differences associated with age, environmental factors and/or&#xD;
      geographical area. For this purpose: a) participants are recruited based on the reference&#xD;
      population regarding age and gender; b) recruitment is done in 5 different geographical areas&#xD;
      in Spain: Andalusia, Asturias, Basque Country, Catalonia and Madrid; c) relevant clinical,&#xD;
      social and environmental data is collected and d) serologic screening (anti-tissue&#xD;
      transglutaminase (tTG) - Immunoglobulin A (IgA) antibodies detection in blood serum) with&#xD;
      histological confirmation (small-intestinal biopsy) is used to detect CD cases and determine&#xD;
      disease prevalence.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>tissue transglutaminase IgA antibodies (tTGA) detection in blood serum (serological CD marker)</measure>
    <time_frame>at the time of recruitment</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">5255</enrollment>
  <condition>Celiac Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants are selected from ambulatory minor surgery departments of the pediatric and&#xD;
        general tertiary referral hospitals in Spain. Regarding age and sex, inclusion is done&#xD;
        reproducing the reference population of each participating Spanish regions (according to&#xD;
        data from the Spanish Statistics Institute).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 1 to ≥80 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heart failure or unstable ischemic cardiopathy&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease or respiratory insufficiency&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Diabetes mellitus type II with vascular complications&#xD;
&#xD;
          -  Hepatic cirrhosis&#xD;
&#xD;
          -  Kidney failure (Creatinine &gt;1.5 mg/dL o glomerular filtration &lt;30 ml /min)&#xD;
&#xD;
          -  Active neoplasm&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Gluten-free diet without CD diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitari Mutua Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Sudria Lopez, MSc</last_name>
      <phone>0034618383015</phone>
      <email>esudria@mutuaterrassa.cat</email>
    </contact>
    <investigator>
      <last_name>Maria Esteve, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037. Epub 2018 Mar 16.</citation>
    <PMID>29551598</PMID>
  </reference>
  <reference>
    <citation>Pratesi R, Gandolfi L, Garcia SG, Modelli IC, Lopes de Almeida P, Bocca AL, Catassi C. Prevalence of coeliac disease: unexplained age-related variation in the same population. Scand J Gastroenterol. 2003 Jul;38(7):747-50.</citation>
    <PMID>12889561</PMID>
  </reference>
  <reference>
    <citation>Beatriz Arau; Meritxell Mariné; Carme Farré; Beatriz Dietl; Roger García-Puig; Laura Martí-Cosconera; Anna Carrasco; Eva Tristán; Teresa Marqués; Víctor Vila; Clàudia Fortuny, Maria Esteve. Història natural de la malaltia celíaca (MC): seguiment longitudinal a llarg termini amb dieta lliure de nens asimptomàtics detectats per cribratge poblacional. Resultats preliminars. XXVII Congrés de la Societat Catalana de Digestologia. Girona: 25-27 de gener de 2018. (Annals de Medicina 2018; Suplements Vol. 101 supl. 1)</citation>
  </reference>
  <reference>
    <citation>Myléus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, Karlsson E, Lagerqvist C, Norström F, Rosén A, Sandström O, Stenhammar L, Stenlund H, Wall S, Carlsson A. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):170-6. doi: 10.1097/MPG.0b013e31818c52cc.</citation>
    <PMID>19516192</PMID>
  </reference>
  <reference>
    <citation>Szajewska H, Shamir R, Chmielewska A, Pieścik-Lech M, Auricchio R, Ivarsson A, Kolacek S, Koletzko S, Korponay-Szabo I, Mearin ML, Ribes-Koninckx C, Troncone R; PREVENTCD Study Group. Systematic review with meta-analysis: early infant feeding and coeliac disease--update 2015. Aliment Pharmacol Ther. 2015 Jun;41(11):1038-54. doi: 10.1111/apt.13163. Epub 2015 Mar 26. Review.</citation>
    <PMID>25819114</PMID>
  </reference>
  <reference>
    <citation>Namatovu F, Lindkvist M, Olsson C, Ivarsson A, Sandström O. Season and region of birth as risk factors for coeliac disease a key to the aetiology? Arch Dis Child. 2016 Dec;101(12):1114-1118. doi: 10.1136/archdischild-2015-310122. Epub 2016 Aug 15.</citation>
    <PMID>27528621</PMID>
  </reference>
  <reference>
    <citation>Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, Beri R, Dolcino M, Valletta E, Corrocher R, Puccetti A. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006 Sep;3(9):e358.</citation>
    <PMID>16984219</PMID>
  </reference>
  <reference>
    <citation>Kahrs CR, Chuda K, Tapia G, Stene LC, Mårild K, Rasmussen T, Rønningen KS, Lundin KEA, Kramna L, Cinek O, Størdal K. Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ. 2019 Feb 13;364:l231. doi: 10.1136/bmj.l231.</citation>
    <PMID>30760441</PMID>
  </reference>
  <reference>
    <citation>Kemppainen KM, Lynch KF, Liu E, Lönnrot M, Simell V, Briese T, Koletzko S, Hagopian W, Rewers M, She JX, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Lernmark Å, Hyöty H, Triplett EW, Agardh D; TEDDY Study Group. Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life. Clin Gastroenterol Hepatol. 2017 May;15(5):694-702.e5. doi: 10.1016/j.cgh.2016.10.033. Epub 2016 Nov 10.</citation>
    <PMID>27840181</PMID>
  </reference>
  <reference>
    <citation>Lindfors K, Lin J, Lee HS, Hyöty H, Nykter M, Kurppa K, Liu E, Koletzko S, Rewers M, Hagopian W, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Petrosino JF, Lloyd RE, Agardh D; TEDDY Study Group. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut. 2020 Aug;69(8):1416-1422. doi: 10.1136/gutjnl-2019-319809. Epub 2019 Nov 19.</citation>
    <PMID>31744911</PMID>
  </reference>
  <reference>
    <citation>Namatovu F, Olsson C, Lindkvist M, Myléus A, Högberg U, Ivarsson A, Sandström O. Maternal and perinatal conditions and the risk of developing celiac disease during childhood. BMC Pediatr. 2016 Jun 8;16:77. doi: 10.1186/s12887-016-0613-y.</citation>
    <PMID>27267234</PMID>
  </reference>
  <reference>
    <citation>Kemppainen KM, Vehik K, Lynch KF, Larsson HE, Canepa RJ, Simell V, Koletzko S, Liu E, Simell OG, Toppari J, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian WA, She JX, Akolkar B, Schatz DA, Atkinson MA, Blaser MJ, Krischer JP, Hyöty H, Agardh D, Triplett EW; Environmental Determinants of Diabetes in the Young (TEDDY) Study Group. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity. JAMA Pediatr. 2017 Dec 1;171(12):1217-1225. doi: 10.1001/jamapediatrics.2017.2905.</citation>
    <PMID>29052687</PMID>
  </reference>
  <reference>
    <citation>Dydensborg Sander S, Nybo Andersen AM, Murray JA, Karlstad Ø, Husby S, Størdal K. Association Between Antibiotics in the First Year of Life and Celiac Disease. Gastroenterology. 2019 Jun;156(8):2217-2229. doi: 10.1053/j.gastro.2019.02.039. Epub 2019 Mar 2.</citation>
    <PMID>30836095</PMID>
  </reference>
  <reference>
    <citation>Riestra S, Fernández E, Rodrigo L, Garcia S, Ocio G. Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening. Scand J Gastroenterol. 2000 Apr;35(4):398-402.</citation>
    <PMID>10831263</PMID>
  </reference>
  <reference>
    <citation>Castaño L, Blarduni E, Ortiz L, Núñez J, Bilbao JR, Rica I, Martul P, Vitoria JC. Prospective population screening for celiac disease: high prevalence in the first 3 years of life. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):80-4.</citation>
    <PMID>15187786</PMID>
  </reference>
  <reference>
    <citation>Mariné M, Farre C, Alsina M, Vilar P, Cortijo M, Salas A, Fernández-Bañares F, Rosinach M, Santaolalla R, Loras C, Marquès T, Cusí V, Hernández MI, Carrasco A, Ribes J, Viver JM, Esteve M. The prevalence of coeliac disease is significantly higher in children compared with adults. Aliment Pharmacol Ther. 2011 Feb;33(4):477-86. doi: 10.1111/j.1365-2036.2010.04543.x. Epub 2010 Dec 19.</citation>
    <PMID>21166832</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

